The mechanisms of metronidazole resistance of Helicobacter pylori: A transcriptomic and biochemical study
Microbial Pathogenesis · 2023-10 · 183 · 106303
DOI: 10.1016/j.micpath.2023.106303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2023-10. Verfasst von Zeyuan Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Laboratory of Metalloproteins, College of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China. Hauptthemen laut MEDLINE: Transcriptome, Helicobacter pylori. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Sun Yat-sen University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Helicobacter pylori (H. pylori) is a bacterial pathogen in the stomach, causing gastritis, gastric ulcer, duodenal ulcer and even gastric cancer. The triple therapy containing one bismuth-containing compound or a proton-pump inhibitor with two antibiotics was the cornerstone of the treatment of H. pylori infections. However the drug resistance of Helicobacter pylori is more and more common, which leads to the continued decline in the radical cure rate. The purpose of this study was to investigate the mechanism of metronidazole resistance of H. pylori through transcriptomics and biochemical characterizations. In this study, a 128-time-higher metronidazole-resistant H. pylori strain compared to the sensitive strain was domesticated, and 374 significantly differential genes were identified by transcriptomic sequencing as compared to the metronidazole-sensitive strain. Through GO and KEGG enrichment analysis, antibiotic-resistance pathways were found to be mainly involved in redox, biofilm formation and ABC transportation, and the results were verified by qRT-PCR. The subsequent biochemical analysis found that the urease activity of the drug-resistant strain decreased, and whereas the capabilities of bacterial energy production, membrane production and diffusion ability increased. The work here will drop hints for the mechanisms of antibiotic-resistance of H. pylori and provide promising biomarkers for the further development of new-kind drugs to treat metronidazole-resistant H. pylori.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Laboratory of Metalloproteins, College of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China.
- The Laboratory of Metalloproteins, College of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China. Electronic address: gerg@mail.sysu.edu.cn.
Förderung
- Sun Yat-sen University
- National Natural Science Foundation of China
Zitieren
APA
Huang, Z., Zhu, Y., Li, X., Yao, Z., & Ge, R. (2023). The mechanisms of metronidazole resistance of Helicobacter pylori: A transcriptomic and biochemical study. Microbial Pathogenesis, 183, 106303. https://doi.org/10.1016/j.micpath.2023.106303
Vancouver
Huang Z, Zhu Y, Li X, Yao Z, Ge R. The mechanisms of metronidazole resistance of Helicobacter pylori: A transcriptomic and biochemical study. Microbial Pathogenesis. 2023;183:106303. doi:10.1016/j.micpath.2023.106303
BibTeX
@article{Huang2023,
author = {Huang, Zeyuan and Zhu, Yulin and Li, Xinhang and Yao, Zihui and Ge, Ruiguang},
title = {The mechanisms of metronidazole resistance of Helicobacter pylori: A transcriptomic and biochemical study},
journal = {Microbial Pathogenesis},
year = {2023},
volume = {183},
pages = {106303},
doi = {10.1016/j.micpath.2023.106303}
}
EUVIMED